These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12673494)

  • 1. An early stage small bowel adenocarcinoma with microsatellite instability phenotype in a case of hereditary nonpolyposis colorectal cancer.
    Furukawa T; Konishi F; Shitoh K; Tsukamoto T; Nagai H
    Int J Colorectal Dis; 2003 May; 18(3):267-70. PubMed ID: 12673494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations and MSI status in primary, synchronous, and metachronous tumors in a family with hereditary nonpolyposis colorectal cancer (HNPCC).
    González-Aguilera JJ; Nejda N; Fernández FJ; Medina V; González-Hermoso F; Barrios Y; Moreno Azcoita M; Fernández-Peralta AM
    Am J Clin Oncol; 2003 Aug; 26(4):386-91. PubMed ID: 12902892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature.
    Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB
    Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is hereditary nonpolyposis colorectal cancer (HNPCC).
    Vasen HF
    Anticancer Res; 1994; 14(4B):1613-5. PubMed ID: 7979195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability analysis in hereditary non-polyposis colon cancer using the Bethesda consensus panel of microsatellite markers in the absence of proband normal tissue.
    Chialina SG; Fornes C; Landi C; de la Vega Elena CD; Nicolorich MV; Dourisboure RJ; Solano A; Solis EA
    BMC Med Genet; 2006 Jan; 7():5. PubMed ID: 16426447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral tongue cancer in a patient with hereditary nonpolyposis colorectal cancer: A case report and review of the literature.
    Ziegler A; Thorpe E
    Oral Oncol; 2019 May; 92():92-93. PubMed ID: 30885722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metachronous colorectal carcinoma with massive submucosal invasion detected by annual surveillance in a Lynch syndrome patient: a case report.
    Utsumi M; Tanakaya K; Mushiake Y; Kunitomo T; Yasuhara I; Taniguchi F; Arata T; Katsuda K; Aoki H; Takeuchi H
    World J Surg Oncol; 2017 Aug; 15(1):140. PubMed ID: 28764791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic characteristics, diagnosis, and treatment of 30 patients with hereditary nonpolyposis colorectal cancer].
    Liu H; Yan Z; Liao G; Yin H; Xie X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):757-61. PubMed ID: 19734583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
    Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas].
    Olschwang S; Bonaïti C; Feingold J; Frébourg T; Grandjouan S; Lasset C; Laurent-Puig P; Lecuru F; Millat B; Sobol H; Thomas G; Eisinger F
    Bull Cancer; 2004 Apr; 91(4):303-15. PubMed ID: 15242312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small bowel carcinoma in hereditary nonpolyposis colorectal cancer.
    Benatti P; Roncucci L; Percesepe A; Viel A; Pedroni M; Tamassia MG; Vaccina F; Fante R; De Pietri S; Ponz de Leon M
    Am J Gastroenterol; 1998 Nov; 93(11):2219-22. PubMed ID: 9820400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects].
    Möslein G
    Praxis (Bern 1994); 2001 Mar; 90(12):483-9. PubMed ID: 11324307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel germline mutations of hMSH2 in a patient with hereditary nonpolyposis colorectal cancer (HNPCC) and in a patient with six primary cancers.
    Okamura S; Koyama K; Miyoshi Y; Monden M; Takami M
    J Hum Genet; 1998; 43(2):143-5. PubMed ID: 9621522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fenotypical diversity of hereditary non-polyposis colorectal carcinoma. Pedigree and genetical analysis of two mutation carrier patients].
    Tanyi M; Kanyári Z; Juhász B; Lukács G; Olasz J; Kámory E; Csuka O; Tóth L; Damjanovich L
    Magy Seb; 2006 Dec; 59(6):411-20. PubMed ID: 17432081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome.
    Risinger JI; Barrett JC; Watson P; Lynch HT; Boyd J
    Cancer; 1996 May; 77(9):1836-43. PubMed ID: 8646682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.